About Xiangmin Cui
Xiangmin Cui is a director at Baylor Genetics.
Form D filings also name Xiangmin Cui as a director at ImmPACT Bio USA, SunnyBay BioTech and LevitasBio.
Xiangmin Cui appears on fund filings for Decheng Capital Global Life.
Xiangmin Cui first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Xiangmin Cui in the role, so the role may have started earlier or lasted longer.
DL
Decheng Capital Global Life
Executive officer, director and promoter
2020 – 2026 · Fund filings for 4 funds
Baylor Genetics Holdings, Inc.
Director
2026 · Houston, TX
Provides genetic testing and diagnostic services for healthcare providers and patients.
Key Colleagues at Startups
The people Xiangmin Cui works with at each company, as listed on that company's latest Form D.
Baylor Genetics Holdings, Inc. · Form D, Jul 16, 2026
BL
Brendan Lee
Scientific Advisory Board Chair
JK
Joel Kaufman
Executive officer
GI
Goki Ishikawa
Director
Kengo Takishima
Chairman, Chief Executive Officer
VT
Victor Tong
Director
DB
David Berger
Chief Legal Officer and Secretary
ImmPACT Bio USA Inc. · Form D/A, Apr 2, 2024
YC
Yvonne Chen
Director
Erez Chimovits
Director
HL
Han Lee
Executive officer
MS
Michal Silverberg
Director
SG
Sheila Guirathi
Director
SR
Sumant Ramachandra
President and Chief Executive Officer, director
YY
Yvonne Yamanaka
Director
CX
Cindy Xiong
Director
SunnyBay BioTech, Inc. · Form D, Jan 27, 2023
FJ
Feng Wang-Johanning
Chief Executive Officer and director
GJ
Gary Johanning
Executive officer
PC
Peter Colabuono
Director
LevitasBio, Inc. · Form D, Jan 15, 2021
MP
Martin Pieprzyk
Chief Executive Officer and director
LS
Lars Steinmetz
Director
VJ
Victor Tong, Jr.
Director
ZW
Zheng Wang
Director